Kidney Disease and Bone: Changing the Way We Look at Skeletal Health
- PMID: 32193793
- PMCID: PMC7395483
- DOI: 10.1007/s11914-020-00580-9
Kidney Disease and Bone: Changing the Way We Look at Skeletal Health
Abstract
Purpose of review: Kidney disease imparts profound skeletal changes, and unlike many other skeletal diseases, cortical bone is predominantly impacted. Significant advances in medical imaging have led to our ability to now obtain high-resolution three-dimensional views of cortical bone. This paper overviews recent work focused on cortical bone imaging, specifically cortical porosity, in kidney disease.
Recent findings: Although a number of clinical papers have used high-resolution imaging to assess cortical bone porosity, the most impactful work involves longitudinal study designs that have assessed cortical porosity changes over time. These latter studies demonstrate dramatic increases in cortical porosity in untreated individuals and a lack of clear efficacy in reversing porosity with treatment (although data are limited). Those papers providing longitudinal assessment, both clinical and pre-clinical, reveal powerful data about cortical porosity and provide a foundation upon which future studies can build.
Keywords: CKD-MBD; Cortical bone; Cortical porosity; HR-pQCT; Imaging.
Figures


Similar articles
-
Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities.Osteoporos Int. 2017 May;28(5):1675-1683. doi: 10.1007/s00198-017-3956-9. Epub 2017 Feb 16. Osteoporos Int. 2017. PMID: 28204954
-
The Efficacy of Low-intensity Vibration to Improve Bone Health in Patients with End-stage Renal Disease Is Highly Dependent on Compliance and Muscle Response.Acad Radiol. 2017 Nov;24(11):1332-1342. doi: 10.1016/j.acra.2017.05.014. Epub 2017 Jun 23. Acad Radiol. 2017. PMID: 28652048 Free PMC article. Clinical Trial.
-
Cortical porosity not superior to conventional densitometry in identifying hemodialysis patients with fragility fracture.PLoS One. 2017 Feb 15;12(2):e0171873. doi: 10.1371/journal.pone.0171873. eCollection 2017. PLoS One. 2017. PMID: 28199411 Free PMC article.
-
Cortical Bone Porosity: What Is It, Why Is It Important, and How Can We Detect It?Curr Osteoporos Rep. 2016 Oct;14(5):187-98. doi: 10.1007/s11914-016-0319-y. Curr Osteoporos Rep. 2016. PMID: 27623679 Review.
-
The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease.J Nephrol. 2017 Oct;30(5):635-643. doi: 10.1007/s40620-017-0433-7. Epub 2017 Sep 12. J Nephrol. 2017. PMID: 28900872 Review.
Cited by
-
CKD Stages, Bone Metabolism Markers, and Cortical Porosity Index: Associations and Mediation Effects Analysis.Front Endocrinol (Lausanne). 2021 Nov 5;12:775066. doi: 10.3389/fendo.2021.775066. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34803931 Free PMC article.
References
-
- Parfitt AM. A structural approach to renal bone disease. J. Bone Miner. Res 1998. p. 1213–20. - PubMed
-
A timeless review, from one of the greatest thought-leaders in metaboli bone disese, that is a must read for anyone interested in kidney disease and bone.
-
- Carvalho C, Magalhães J, Neto R, Pereira L, Branco P, Adragão T, et al. Cortical bone analysis in a predialysis population: a comparison with a dialysis population. J Bone Miner Metab. 2017;35:513–21. - PubMed
-
- Carvalho C, Magalhães J, Pereira L, Simóes-Silva L, Castro-Ferreira I, Frazão JM. Evolution of bone disease after kidney transplantation: A prospective histomorphometric analysis of trabecular and cortical bone. Nephrology. 2016;21:55–61. - PubMed
-
- Santos MFP, Hernández MJ, de Oliveira IB, Siqueira FR, Dominguez WV., dos Reis LM, et al. Comparison of clinical, biochemical and histomorphometric analysis of bone biopsies in dialysis patients with and without fractures. J Bone Miner Metab; 2019;37:125–33. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials